Find Clinical Trials
Efficacy and safety of 3 doses of S 38093 (2, 5 and 20 mg/day) versus placebo, in co-administration with donepezil (10 mg/day) in patients with moderate Alzheimer’s Disease. A 24-week international, multi-centre, randomised, double-blind, placebo-controlled phase IIb study.
Servier Protocol Code:
CL2-38093-012
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2011-005862-40
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
Interventions / Treatments
The treatment(s) given to the participants in the study.
- Alzheimer's disease
- S038093
Other study id numbers
Other identification numbers the study may be known by.
- CL2-38093-012